Perspective Therapeutics (CATX) Current Deferred Revenue (2024)

Perspective Therapeutics has disclosed Current Deferred Revenue across 1 years of filings, most recently posting $1.4 million for Q4 2024.

• In Q4 2024, Current Deferred Revenue changed N/A year-over-year to $1.4 million; the TTM figure through Dec 2024 stood at $1.4 million (changed N/A YoY), while the FY2024 annual figure was $1.4 million, changed N/A from the prior year.
• Current Deferred Revenue came in at $1.4 million for Q4 2024 at Perspective Therapeutics, roughly flat from $1.4 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $1.4 million in Q1 2024 to a low of $1.4 million in Q1 2024.